50: How to create a first-in-class drug? With Lisa Patel from Istesso

On this episode, we have Lisa Patel, who is the CEO and co-founder of the drug discovery & development company Istesso. They work in the emerging field of immunometabolism, harnessing the connection between immunology & metabolism to help a patient return to their natural rhythm. Lisa wanted to further her passion to eliminate conditions like rheumatoid arthritis by creating a ‘first in class’ medication that could change the way we treat autoimmune conditions. Hear about her experiences from working at a world-class pharma company, her views on being mentioned in a leading financial column, the role of big tech in drug discovery and her advice for entrepreneurs in the STEM field. On the show, you’ll find out: How Lisa’s experience at GlaxoSmithKline helped her start Istesso How Istesso has successfully gained support from Innovate UK How Lisa’s motivation to create efficient and effective medical solutions is powering Istesso’s work How patient care became a driving force of drug development at Istesso How she developed an arsenal of new skills as an entrepreneur How restoring the body’s ‘natural rhythm’ is a core part of immunometabolism research How Istesso is developing a new drug that could replace a common drug with many side effects used to treat rheumatoid arthritis Her passion for solving the ongoing symptoms of patients suffering from autoimmune diseases How deep tech and AI are helping in clinical trials and drug research Her advice for women wanting to enter STEM careers or become entrepreneurs in the field LinkedIn: Lisa Patel<br /> Website: https://istesso.co.uk/ Host: Dr Vinay Shankar<br /> Website: https://www.oncedaily.co<br /> iTunes: 15 Minutes With The Doctor<br /> Spotify: 15 Minutes With The Doctor